UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 363

Sortiert nach

How I treat adenovirus in hematopoietic stem cell transplant recipients

Blood, 2010-12, Vol.116 (25), p.5476-5485

2010

Link zum Volltext

Verfügbarkeit prüfen

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Link zum Volltext

Verfügbarkeit prüfen

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Molecular therapy, 2017-01, Vol.25 (1), p.249-258

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Link zum Volltext

Verfügbarkeit prüfen

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Current opinion in infectious diseases, 2018-08, Vol.31 (4), p.292-300

2018

Link zum Volltext

Verfügbarkeit prüfen

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Blood, 2013-06, Vol.121 (26), p.5113-5123

2013

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

Cytotherapy (Oxford, England), 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

British journal of haematology, 2023-08, Vol.202 (4), p.874-878

2023

Link zum Volltext

Verfügbarkeit prüfen

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical cancer research, 2023-01, Vol.29 (2), p.324-330

2023

Link zum Volltext

Verfügbarkeit prüfen

Fine-tuning the CAR spacer improves T-cell potency

Oncoimmunology, 2016-12, Vol.5 (12), p.e1253656-e1253656

2016

Link zum Volltext

Verfügbarkeit prüfen

Antiviral T-cell therapy

Immunological reviews, 2014-03, Vol.258 (1), p.12-29

2014

Link zum Volltext

Verfügbarkeit prüfen

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

Molecular therapy, 2012-08, Vol.20 (8), p.1622-1632

2012

Link zum Volltext

Verfügbarkeit prüfen

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Clinical cancer research, 2017-07, Vol.23 (14), p.3499-3509

2017

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

Molecular therapy, 2014-06, Vol.22 (6), p.1211-1220

2014

Link zum Volltext

Verfügbarkeit prüfen

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Is cancer gene therapy an empty suit?

The lancet oncology, 2013-10, Vol.14 (11), p.e447-e456

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Molecular therapy, 2013-11, Vol.21 (11), p.2113-2121

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Blood, 2024-04, Vol.143 (17), p.1726

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Blood, 2014-06, Vol.123 (25), p.3895-3905

2014

Link zum Volltext

Verfügbarkeit prüfen

Improving T cell therapy for cancer

Annual Review of Immunology, 2007-01, Vol.25 (1), p.243-265

2007

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Blood, 2009-11, Vol.114 (19), p.4283-4292

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

Frontiers in immunology, 2023, Vol.14, p.1299512-1299512

2023

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1415-1425

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(332)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Life Sciences & Biomedicine
(184)
Humans
(129)
Female
(61)
Male
(58)
Immunotherapy
(45)
Immunology
(43)
Medicine, Research & Experimental
(39)
Research & Experimental Medicine
(39)
Animals
(38)
Hematology
(38)
Hematology, Oncology And Palliative Medicine
(34)
Oncology
(34)
T-Lymphocytes, Cytotoxic - Immunology
(33)
Adult
(31)
Biological And Medical Sciences
(29)
Middle Aged
(28)
Lymphocytes
(25)
Medical Sciences
(25)
Antigens
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

How I treat adenovirus in hematopoietic stem cell transplant recipients

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Fine-tuning the CAR spacer improves T-cell potency

Antiviral T-cell therapy

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Is cancer gene therapy an empty suit?

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Improving T cell therapy for cancer

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Suchergebnisse filtern